GAMMA Investing’s Usana Health Sciences USNA Stock Holding History

GAMMA Investing’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.47K	Buy	350 +91	+35%	+$1.71K	﹤0.01%	3326
2026 Q1	$4.53K	Buy	259 +104	+67%	+$2.06K	﹤0.01%	3395
2025 Q4	$3.04K	Sell	155 -623	-80%	-$12.9K	﹤0.01%	3470
2025 Q3	$21.4K	Buy	778 +58	+8%	+$1.78K	﹤0.01%	2476
2025 Q2	$22K	Buy	720 +410	+132%	+$11.6K	﹤0.01%	2403
2025 Q1	$8.36K	Buy	310 +293	+1,724%	+$9.28K	﹤0.01%	2838
2024 Q4	$610	Sell	17 -171	-91%	-$6.39K	﹤0.01%	3538
2024 Q3	$7.13K	Sell	188 -144	-43%	-$5.92K	﹤0.01%	2594
2024 Q2	$15K	Buy	332 +216	+186%	+$9.94K	﹤0.01%	2035
2024 Q1	$5.63K	Buy	116 +104	+867%	+$5.09K	﹤0.01%	2359
2023 Q4	$562	Buy	+12	New	+$607	﹤0.01%	2938

Other funds holding USNA

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PCM

Park Capital Management Madison, Wisconsin $170M AUM 83.62% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

CAL

Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing's USNA Position: Q2 2026 in Review

GAMMA Investing increased its Usana Health Sciences (USNA) stake by 35% in Q2 2026, buying an estimated $1.71K and bringing the position to 350 shares worth $7.47K. The position accounts for ﹤0.01% of the portfolio, ranked #3326.

GAMMA Investing first reported a position in USNA in Q4 2023 and has held it in 11 quarters since. The position peaked at $22K in Q2 2025. 9 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

GAMMA Investing held 350 shares of Usana Health Sciences worth $7.47K as of Q2 2026.
GAMMA Investing bought 91 Usana Health Sciences shares in Q2 2026, an estimated $1.71K.
Usana Health Sciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3326 holding.
GAMMA Investing first reported a position in Usana Health Sciences in Q4 2023 and has held it in 11 quarters since.
GAMMA Investing's Usana Health Sciences position peaked at $22K in Q2 2025.
9 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.